Brain metastasis-related microRNAs in patients with advanced breast cancer
Open Access
- 11 October 2019
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 14 (10), e0221538
- https://doi.org/10.1371/journal.pone.0221538
Abstract
Brain metastasis is a major distant metastasis occurring in patients with advanced breast cancer, and is associated with poor prognosis. MicroRNAs (miRNAs) have a strong influence on various oncological functions and have been reported as potential biomarkers for detecting distant metastasis. Specific biomarkers and unique miRNAs for brain metastasis have yet to be reported. The aim of this study was to identify novel miRNAs in serum, to assist in the diagnosis of brain metastasis in patients with advanced breast cancer. We retrospectively analyzed the medical records of patients with breast cancer and collected clinical data. In addition, we evaluated serum miRNA profiles in patients with breast cancer, with and without brain metastasis, using high-sensitivity microarrays. All patients underwent computed tomography or magnetic resonance imaging brain imaging tests. A total of 51 serum samples from patients with breast cancer and brain metastasis, stored in the National Cancer Center Biobank, were used, and 28 serum samples were obtained from controls without brain metastasis. Two miRNAs, miR-4428 and miR-4480, could significantly distinguish patients with brain metastasis, with area under the receiver operating characteristic curve (AUC) values of 0.779 and 0.781, respectively, while a combination of miR-4428 and progesterone receptor had an AUC value of 0.884. No significant correlations were identified between the expression levels of these two miRNAs in serum and clinical data. We conclude that serum miR-4428 and miR-4480 may be useful as biomarkers for predicting brain metastasis in patients with breast cancer.Keywords
This publication has 44 references indexed in Scilit:
- Prolyl-4-hydroxylase α subunit 2 promotes breast cancer progression and metastasis by regulating collagen depositionBMC Cancer, 2014
- Circulating microRNA-92a and microRNA-21 as novel minimally invasive biomarkers for primary breast cancerZeitschrift für Krebsforschung und Klinische Onkologie, 2012
- MicroRNAs: miRRORS of health and diseaseTranslational Research, 2011
- MicroRNA-1258 Suppresses Breast Cancer Brain Metastasis by Targeting HeparanaseCancer Research, 2011
- Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancerBreast Cancer Research, 2010
- MicroRNA expression profiling of human metastatic cancers identifies cancer gene targetsThe Journal of Pathology, 2009
- Circulating microRNAs in breast cancer and healthy subjectsBMC Research Notes, 2009
- Multicenter Phase II Study of Lapatinib in Patients with Brain Metastases from HER2-Positive Breast CancerClinical Cancer Research, 2009
- Hepatitis B virus subgenotypes D1 and D3 are prevalent in PakistanBMC Research Notes, 2009
- Clinicopathologic characteristics and prognostic factors in 420 metastatic breast cancer patients with central nervous system metastasisCancer, 2007